Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies
- PMID: 8096749
- DOI: 10.1007/978-1-4615-3518-8_41
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies
Similar articles
-
An update of Scandinavian studies of osteosarcoma.Cancer Treat Res. 1993;62:293-8. doi: 10.1007/978-1-4615-3518-8_35. Cancer Treat Res. 1993. PMID: 8096745 Review. No abstract available.
-
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.Cancer Treat Res. 1993;62:173-5. doi: 10.1007/978-1-4615-3518-8_20. Cancer Treat Res. 1993. PMID: 8096730 Review. No abstract available.
-
Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.Cancer Treat Res. 1993;62:361-4. doi: 10.1007/978-1-4615-3518-8_45. Cancer Treat Res. 1993. PMID: 7682095 Clinical Trial. No abstract available.
-
The multi-institutional osteosarcoma study: an update.Cancer Treat Res. 1993;62:261-7. doi: 10.1007/978-1-4615-3518-8_31. Cancer Treat Res. 1993. PMID: 7682087 Clinical Trial. No abstract available.
-
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.Cancer Treat Res. 1993;62:299-308. doi: 10.1007/978-1-4615-3518-8_36. Cancer Treat Res. 1993. PMID: 7682090 Clinical Trial. No abstract available.
Cited by
-
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma.J Bone Oncol. 2019 Jun 12;17:100245. doi: 10.1016/j.jbo.2019.100245. eCollection 2019 Aug. J Bone Oncol. 2019. PMID: 31293882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical